Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01331694 · clinicaltrials.gov ↗

COMPLETED

Status

76130

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: fluticasone/salmeterol combination (FSC) 250/50mcg
DRUG: tiotropium
DRUG: ipratropium bromide alone or in fixed dose combination with albuterol

Sponsor

GlaxoSmithKline